This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking neurokinin B, a receptor involved in the ...

which included information on individual patient treatment assignment (placebo versus active agent), dose and the frequency and severity of hot flashes. Daily hot flash frequency was multiplied by ...

Hormone therapy may be the most effective treatment for hot flashes and night sweats, also called the vasomotor symptoms of menopause. But there are effective non-hormone therapies, too.

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Menopausal Hot Flashes market by Treatment Type, Distribution channel - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's ...

Although the results of these studies demonstrate that venlafaxine, fluoxetine, and paroxetine reduce hot flashes ... information beyond 13 weeks of treatment. The primary study endpoints were ...